Telephone Genetic Counseling for High-Risk Women Undergoing <i>BRCA1</i> and <i>BRCA2</i> Testing: Rationale and Development of a Randomized Controlled Trial
Beth N. Peshkin(Georgetown University), Marc D. Schwartz(Guardia Civil), Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Tiffani A. DeMarco(Georgetown University), Diana Moglia(Good Samaritan University Hospital), Karen Brown(University of Leicester), Kristi D. Graves(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Andrea Forman(Fox Chase Cancer Center)
Cited by 1
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253